Thirona launches AI software for Cystic Fibrosis
admin2022-04-04T12:02:09+00:00Thirona developed an AI algorithm that revolutionizes cystic fibrosis (CF) care.
Thirona developed an AI algorithm that revolutionizes cystic fibrosis (CF) care.
CAD4COVID-CT can now help even more people with the permission from the FDA.
With the COVID-19 pandemic ongoing, Thirona starts a new collaboration to further improve and accelerate the detection of the virus.
Artificial intelligence tool CAD4COVID-XRay can perform comparably to radiologists in triaging suspected COVID-19 cases by analysing chest X-rays.
We are honoured that CAD4COVID has been nominated for the Top 10 innovation at COVID-19 Innovation Challenge 2020 organized by the UNECA.
We look forward to working with our users in New Zealand on the analysis of their retinal images.
Our Notified Body has granted CE certifications for both our CAD4COVID-CT and CAD4COVID-XRay solutions.
We look forward to working with our South Korean users on quantitative analysis of their chest CT scans.
We are proud to launch CAD4COVID-CT, our artificial intelligence software for the analysis of COVID-19 on CT scans.
Thirona has screened over 6 million people in 40 countries with its proven CAD4TB solution.
RetCAD is validated in a scientific study and is also approved for clinical use in Singapore.
The paper demonstrates that this latest version of CAD4TB outperforms all previous versions; the software is now operating at the level of expert human readers in detecting TB from chest X-Ray.